Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/07/2003US6629835 Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2
10/07/2003CA2373821C Topical compositions for prostaglandin e1 delivery
10/07/2003CA2362479C Aerosol hair spray compositions comprising combinations of silicone-grafted copolymers
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2291620C Production method of isoxazolidinedione compound
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2279692C Novel 4-amino-1-arylpyridin-2-ones having anticonvulsive activity and processes for their preparation
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2261267C Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
10/07/2003CA2258146C Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
10/07/2003CA2251003C New compounds, derivatives of n-aryl 2-hydroxyalkylamides
10/07/2003CA2250077C Use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders
10/07/2003CA2244402C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/07/2003CA2241288C Pseudoephedrine hydrochloride extended release tablets
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2208520C Diclavulanate salt with a diamino ether and process of preparation
10/07/2003CA2162854C Method for treating neurological disorders
10/07/2003CA2140890C Medicament for inhibiting neutrophil elastase and cathepsin g
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/07/2003CA2091602C Highly concentrated amino acid solution
10/07/2003CA2074004C 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
10/05/2003CA2380791A1 Composition to alleviate pain and topical method of applying same
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080864A1 Histone deacetylase: novel molecular target of neurotoxicity
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080810A2 αAED AND βAED REGULATION OF NUCLEAR TRANSCRIPTION, GENE REGULATION, AND/OR GENE EXPRESSION
10/02/2003WO2003080803A2 Methods of using farnesoid x receptor (fxr) agonists
10/02/2003WO2003080794A2 Inhibition of rna function by delivery of inhibitors to animal cells
10/02/2003WO2003080713A1 Supercritical fluid extraction of vitreoretinal silicone tamponades
10/02/2003WO2003080643A1 Process for producing triterpene derivative
10/02/2003WO2003080642A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring
10/02/2003WO2003080641A1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof
10/02/2003WO2003080637A1 Process for isolation of eupalitin (3-0-beta-d-galactopyranoside) from boerhavia diffusa
10/02/2003WO2003080635A1 Crystals of glucopyranosyloxybenzyl benzene derivative
10/02/2003WO2003080634A1 Novel glucopyranoside and a process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof
10/02/2003WO2003080633A1 Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
10/02/2003WO2003080630A2 Phosphate transport inhibitors
10/02/2003WO2003080629A2 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080624A2 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
10/02/2003WO2003080620A1 Inhibitors of nucleoside phosphorylases and nucleosidases
10/02/2003WO2003080612A1 Dipyridodiazepinones as reverse transcriptase inhibitors
10/02/2003WO2003080610A1 Imidazopyridine derivatives as kinase inhibitors
10/02/2003WO2003080608A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080605A1 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
10/02/2003WO2003080603A1 Benzodiazepine derivative
10/02/2003WO2003080600A1 Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities
10/02/2003WO2003080599A1 Stable hydrate of a muscarinic receptor antagonist
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080593A1 Hydrophilic polymers-flavonoids conjugates and pharmaceutical compositions comprising them
10/02/2003WO2003080592A1 2-pyrone compounds and use thereof
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080585A1 Novel aminobenzamide derivative
10/02/2003WO2003080583A1 Medicine for prevention and/or therapy of cardiomyopathy
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080184A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/02/2003WO2003080183A1 Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids
10/02/2003WO2003080182A1 Use of cysteine protease-inhibitors for treating illnesses
10/02/2003WO2003080181A2 Storage stable eplerenone formulation
10/02/2003WO2003080171A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
10/02/2003WO2003080144A1 Composition for hard tissue augmentation
10/02/2003WO2003080138A1 Preparation and method for improving the regenerability of cartilaginous tissue, which is damaged by trauma, wear or disease, or for prophylactically preventing the deterioration of cartilage
10/02/2003WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080114A2 Imidazoquinoline adjuvants for vaccines
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080110A1 Topical pathogenic-tissue-destroying liquid
10/02/2003WO2003080108A1 Stable pharmaceutical composition containing factor viii
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080103A1 Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents
10/02/2003WO2003080092A1 Water soluble bioactive fraction isolated from gum resin exudate of boswellia serrata, process for isolation thereof, composition containing said fraction and use thereof
10/02/2003WO2003080087A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation
10/02/2003WO2003080084A1 A process for the extraction of anthocyanins from black rice and composition thereof
10/02/2003WO2003080081A2 Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof
10/02/2003WO2003080080A1 Cyclodextrin compositions and methods of treating viral infections
10/02/2003WO2003080079A1 Use of sulfoalkyl ether cyclodextrin as a preservative
10/02/2003WO2003080078A1 Treatment of pre-core hepatitis b virus mutant infections
10/02/2003WO2003080077A1 Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination
10/02/2003WO2003080076A1 Novel therapeutic use of riboside of 5-aminoimidazole-4- carboxamide (acadesine)
1 ... 5320 5321 5322 5323 5324 5325 5326 5327 5328 5329 5330 5331 5332 5333 5334 5335 5336 5337 5338 5339 5340 ... 7860